-
Startseite
-
a-t-Archiv
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Geschenkabo
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
Volume 37, 13 January 2006 1/2006
 
  SPOT ON
 

Antidepressant drugs: opinion of the professional associations
Resistance to oseltamivir (TAMIFLU)

 
  NEW ON THE MARKET
 

Omalizumab (XOLAIR) for allergic asthma

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Antibiotics for atherosclerosis: no benefit - but harmful?
Critical ischemia of the lower limbs: bypass or angioplasty?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Misleading labelling of drugs
Biologicals for psoriasis

 
  QUALITY CHECK
 

Capsule-preparations with 50 mg doxepine (e.g. SINQUAN)

 
  IN BRIEF
 

Finally: no beta-carotene for smokers
Sweetener aspartame carcinogenic?

 
  CURRENT ADR NETWORK REPORT

Ketoacidosis with ziprasidone (ZELDOX)

 
  SIDE EFFECTS
 

Macular edema with glitazones
Acid blocking agents and clostridium infections

 
© arznei-telegramm 1/2006